Wellstat Wins $56M In Row With Chemo Antidote Sales Partner
Oncology drug developer Wellstat Therapeutics Corp. prevailed in its breach of contract claims against BTG International Inc. on Tuesday when a Delaware Chancery Court judge awarded it $55.8 million in damages...To view the full article, register now.
Already a subscriber? Click here to view full article